Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397937 · ClinicalTrials.gov registry record · NA
SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes
A NA study of Stroke and Social Determinants of Health, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 275
- Enrollment target
- 1
- Study location
NCT06397937: Recruiting NA study of Stroke and Social Determinants of Health, sponsored by Columbia University.
NCT06397937 is a NA study of Stroke and Social Determinants of Health that is actively recruiting participants, run by Columbia University. The registered enrollment target is 275 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06397937, a NA study of Stroke and Social Determinants of Health, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Goal: To test the hypothesis that among stroke patients 18-75 years with ≥3 SDOH risk factors, SHIFT will improve: (1) functional outcomes as measured by the SIS (Primary Outcome), (2) physiological outcomes as measured by changes in blood pressure and cognition, (secondary outcomes) and (3) epigenetic allostatic load biomarkers (exploratory outcome) such as DNA methylation (DNAm) and telomere length, at 6 months and 1-year post-stroke, compared with usual care (UC).
Primary Outcome
a validated measure of disability and health-related quality of life after stroke
Conditions Studied
Interventions
- BEHAVIORAL SHIFT team intervention
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2024-09-15 |
| Est. Completion | 2029-01-31 |
| Phase | NA |
What NCT06397937 shows while recruiting
NCT06397937 is an interventional study that assigns participants to a tested intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which SHIFT team intervention is the first listed.
NCT06397937 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06397937 about?
NCT06397937 is a clinical study titled "SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes". Primary Goal: To test the hypothesis that among stroke patients 18-75 years with ≥3 SDOH risk factors, SHIFT will improve: (1) functional outcomes as measured by the SIS (Primary Outcome), (2) physiological outcomes as measured by changes in blood pressure and cognition, (secondary outcomes) and (3...
What is the current status of trial NCT06397937?
This trial is currently recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2024-09-15. Estimated completion is 2029-01-31.
What conditions does trial NCT06397937 study?
This clinical trial studies the following conditions: Stroke, Social Determinants of Health.
What interventions are being tested in trial NCT06397937?
The interventions under investigation include: SHIFT team intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06397937?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06397937 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06397937's enrollment target sits among peer trials
275 80th of 454 higher than 375 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI